ReviewInternational journal of molecular sciences2021

Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: "The Earlier, the Better" in Therapy with Incretin-Based Medicine.

Hideaki Kaneto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.